XML 40 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Note 3 - Stockholders' Deficit
 9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
3.
   Stockholders’ Deficit
 
The Company has authorized
10,000,000
shares of preferred stock at
$0.001
par value,
5,000,000
of which are designated as “Series A Convertible Preferred Stock” at
$0.001
par value and
100,000,000
authorized shares of common stock at
$0.001
par value (“Common Stock”).
 
Shares of Series A Convertible Preferred Stock do
not
accumulate dividends and are convertible into shares of Common Stock on a
one
-for-
one
basis. Additionally, each share entitles the holder to
100
votes and, with respect to dividend and liquidation rights, the shares rank pari passu with the Company’s Common Stock.
 
The Company announced and approved a reverse stock split effective
July 15, 2019
at a ratio of
1
for
3,
whereby every
3
shares of common stock issued and outstanding were automatically reclassified and combined into
one
share of common stock (“Reverse Stock Split”). The Reverse Stock Split has been reflected retroactively in these financial statements for all periods presented.
 
During the
nine
months ended
September 30, 2019,
the Company issued
30,833
shares of Common Stock at a cash price of
$3.00
per share for a total of
$92,500
and
3,333
shares of Common Stock for an aggregate cash price of
$6,500
for subscriptions received during the year ended
December 31, 2018.
 
During the
nine
months ended
September 30, 2019
the Company issued
3,334
shares of Common Stock for an aggregate cash price of
$10,000
for subscriptions received during the year ended
December 31, 2018.
 
On
April 10, 2019
the Company sold
51,282
shares of Common Stock and a Warrant, exercisable for a period of
5
years, to purchase
33,333
shares of Common Stock at an exercise price of
$1.95
per share, to a
third
party for aggregate consideration of
$100,000.
 
On or about
May 7, 2019
the Company sold
25,641
shares of Common Stock to a
third
party at a price of
$1.95
per share, for aggregate consideration of
$50,000.
 
On or about
May 22, 2019
the Company sold
12,821
shares of Common Stock and a Warrant, exercisable for a period of
5
years, to purchase
6,410
shares of Common Stock at an exercise price of
$1.95
per share to a
third
party for aggregate consideration of
$25,000.
 
On or about
June 4, 2019
the Company sold
51,282
shares of Common Stock and a Warrant, exercisable for a period of
5
years, to purchase
25,641
shares of Common Stock at an exercise price of
$1.95
per share, to a
third
party for aggregate consideration of
$100,000.
 
On
August 29, 2019
the Company sold
12,821
shares of Common Stock and a Warrant, exercisable for a period of
5
years, to purchase
6,411
shares of Common Stock at an exercise price of
$1.95
per share, to a
third
party for aggregate consideration of
$25,000.